Viral Attenuation

Viral Attenuation is a methodological strategy in oncolytic virotherapy involving the reduction of viral pathogenicity while preserving replicative capacity and immunogenicity, typically through genetic modifications or serial passaging to enable selective tumor cell targeting.

199

Publications

11.3K

Citations

1.2K

Authors

345

Institutions

Publications per year

2017–2026

43

Authors

1.2K

  1. AM
    Andrew Macadam

    National Institute for Biological Standards and Control, United Kingdom

    10 publications · 795 citations

    10

    h-index

  2. VR
    Vincent R. Racaniello

    Columbia University, United States

    7 publications · 1K citations

    7

    h-index

  3. PD
    P. D. Minor

    National Institute for Biological Standards and Control, United Kingdom

    5 publications · 648 citations

    5

    h-index

  4. PD
    Philip D. Minor

    National Institute for Biological Standards and Control, United Kingdom

    5 publications · 263 citations

    5

    h-index

  5. JW
    Jeffrey W. Almond

    University of Reading, United Kingdom

    5 publications · 187 citations

    5

    h-index

1–5 of 1.2K

Venues

  1. Journal of Virology

    JVI · 41 publications · 3.2K citations

    30

    h-index

  2. Virology

    11 publications · 639 citations

    10

    h-index

  3. PubMed

    Repository · 10 publications · 202 citations

    10

    h-index

  4. Journal of General Virology

    8 publications · 512 citations

    9

    h-index

  5. Proceedings of the National Academy of Sciences

    PNAS · 7 publications · 750 citations

    7

    h-index

1–5